Evidence map›Paper›PMID 40486592›Full record

ReviewAnnals of medicine and surgery (2012)2025

The vitamin C paradigm: new frontiers in blood transfusion.

Emmanuel Ifeanyi Obeagu

Abstract readReview
In one paragraph

Review in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. A review of the iron requirements and its determination in commercial poultry.Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2026
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Emmanuel Ifeanyi ObeaguDepartment of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin C, a potent antioxidant, is gaining attention in the field of transfusion medicine for its potential to enhance blood transfusion practices. Recent studies suggest that vitamin C can significantly improve erythrocyte preservation by mitigating oxidative damage during storage, thereby maintaining cell membrane integrity and functionality. This preservation is crucial for ensuring the efficacy and safety of transfused blood, ultimately leading to better patient outcomes. In addition to its role in erythrocyte preservation, vitamin C has been shown to modulate immune responses, which can be particularly beneficial in reducing the risks associated with transfusion-related immunomodulation (TRIM). By influencing both innate and adaptive immunity, vitamin C can help mitigate adverse immune reactions and improve the overall clinical outcomes for transfusion recipients. These immune-modulating properties underscore the potential of vitamin C to address some of the critical challenges in transfusion medicine. Furthermore, clinical trials have demonstrated that the incorporation of vitamin C in transfusion protocols can lead to enhanced recovery rates and reduced incidence of transfusion-related complications. The multifaceted benefits of vitamin C, including its antioxidant defense, immune support, and metabolic regulation, highlight its promise as a transformative agent in blood transfusion practices. As research continues to uncover the optimal use of vitamin C in this context, it is poised to become a pivotal element in improving transfusion efficacy and patient care.

Indexed as

antioxidant therapyblood storageerythrocyte preservationtransfusion medicinevitamin C

Identifiers

PMID40486592
PMCPMC12140693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.